发明授权
- 专利标题： Antibody to GALP and uses thereof
- 专利标题（中）： GALP抗体及其用途
-
申请号： US10490917申请日： 2002-09-25
-
公开(公告)号： US07173112B2公开(公告)日： 2007-02-06
- 发明人: Hirokazu Matsumoto , Yasuko Horikoshi , Chieko Kitada , Tetsuya Ohtaki
- 申请人： Hirokazu Matsumoto , Yasuko Horikoshi , Chieko Kitada , Tetsuya Ohtaki
- 申请人地址： JP Osaka
- 专利权人： Takeda Pharmaceutical Company Limited
- 当前专利权人： Takeda Pharmaceutical Company Limited
- 当前专利权人地址： JP Osaka
- 代理机构： Edwards Angell Palmer & Dodge, LLP
- 代理商 David G. Conlin; Kathryn A. Piffat
- 优先权： JP2001-294528 20010926
- 国际申请： PCT/JP02/09840 WO 20020925
- 国际公布： WO03/027150 WO 20030403
- 主分类号： C07K16/00
- IPC分类号： C07K16/00
摘要：
The present invention intends to provide a novel monoclonal antibody having a binding specificity to GALP or its derivative, which is useful in developing therapeutic agents, preventive agents or diagnostic agent for diseases associated with GALP or its derivative, and a method of quantifying GALP using the antibody. More specifically, the present invention provides an antibody specifically reacting with a partial peptide in the C-terminal region of a polypeptide having the amino acid sequence represented by SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 3, or its derivative, and a method of quantifying GALP or its derivative.
公开/授权文献
- US20040214230A1 Antibody and use thereof 公开/授权日：2004-10-28
信息查询
